š« A lung. Alive. Outside the body.
- Jun 19
- 1 min read
This is made possible by Ex Vivo Lung Perfusion (EVLP), a technology that keeps donor lungs warm, ventilated, and functioning outside the body before transplantation.
Using EVLP, clinicians can assess, preserve, and even treat donor lungs before they are transplanted into a patient.
At LifeLUNG, we're taking that technology further. In our ongoing research, we are developing EVLP into a more advanced treatment platform, with two specific goals:
1.ā ā Testing gene therapy delivered during EVLP, before transplantation.
2.ā ā Pioneering a novel, more physiological approach using negative pressure ventilation and rotation to better mimic natural lung function.
We are currently validating these concepts in preclinical models, with the long-term aim of improving donor lung quality, reducing post-transplant complications, and ultimately saving more lives.
Better treatments. Better lungs. More lives saved.
š„ This animation illustrates EVLP technology and its potential as a treatment platform before transplantation.
š· Concept and animation by Viva Sciences Design
Funded by the European Union under the Marie SkÅodowska-Curie Actions (MSCA) programme, Grant No. 101222715 (LifeLUNG). šŖšŗ
